Insiders · Profile

Capps Kathleen S.

See Remarks at ENANTA PHARMACEUTICALS. Filing since 2 Dec 2025. CIK 0002085127

Company
Date
Role
Action
Shares
Amount
Of holding
5 Dec 2025
See Remarks
Sold at will
323
$4.60K
3.7%
2 Dec 2025
See Remarks
Sold at will
207
$2.89K
2.3%
2 decisions on file.